Procedure | Before treatment | During treatment | Months after treatment | ||||
---|---|---|---|---|---|---|---|
0 | 3 | 6 | 12 | 24 | |||
Planning FDG-PET/CT-scan | x | Â | Â | Â | Â | Â | Â |
Acute toxicity (CTC v2.0) | Â | x | x | x | Â | Â | Â |
Late toxicity (RTOG-EORTC) | Â | Â | Â | x | x | x | x |
Assessment of thyroid function (Blood analysis) | x | Â | Â | Â | x | x | x |
Dysphagia related quality of life (PSS-HN, SWAL-QOL) | x | Â | Â | x | x | x | x |
Assessment of swallowing function (Water swallowing test) | x | Â | Â | x | Â | x | x |
Xerostomia related quality of life (GRIX) | x | Â | Â | x | x | x | x |
Assessment salivary gland function (sialometry, sialochemistry) | x | Â | Â | x | Â | x | x |
General quality of life (EORTC QLQ-C30, EORTC H&N35) | x | Â | Â | x | x | x | x |
Assessment of recurrence | Â | Â | each follow-up visit |